The CDKN2A Gene Melanoma Cutaneous Malignant Familial Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the CDKN2A gene, which are strongly associated with an increased risk of developing familial cutaneous malignant melanoma. This test is particularly relevant for individuals with a family history of melanoma, as it can provide crucial information regarding their genetic predisposition to this aggressive form of skin cancer. By identifying specific genetic mutations, the test enables healthcare professionals to recommend personalized preventive measures, surveillance, and, if necessary, early intervention strategies to manage the risk. The cost of this comprehensive genetic test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze and interpret the genetic data.
The "POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility to Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to assess an individual's susceptibility to a specific form of melanoma known as Cutaneous Malignant Melanoma Familial Type 10. This condition is characterized by a mutation in the POT1 gene, which plays a crucial role in the protection of telomeres, the structures at the ends of chromosomes. Mutations in the POT1 gene can lead to telomere dysfunction, contributing to the development of melanoma, a serious form of skin cancer.
The test is aimed at individuals who have a family history of melanoma or who have been identified as being at potential risk due to genetic factors. By analyzing a sample of the individual's DNA, the test seeks to identify mutations in the POT1 gene that are associated with an increased risk of developing this type of melanoma. Early identification of such mutations can be critical in taking preventative measures or in implementing early treatment strategies for those at risk.
The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the valuable insight it provides into an individual's cancer risk profile. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test represents a significant step forward in personalized medicine and cancer prevention.
The XRCC3 Gene Melanoma Cutaneous Malignant Familial Type 6 Susceptibility genetic test is a specialized diagnostic tool designed to assess an individual's risk of developing familial type 6 cutaneous malignant melanoma, a type of skin cancer. This test focuses on identifying mutations in the XRCC3 gene, which plays a crucial role in DNA repair and maintaining genomic stability. Mutations in this gene can lead to an increased susceptibility to developing melanoma, a serious and potentially deadly form of skin cancer characterized by the uncontrolled growth of pigment-producing cells.
The test is performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities. The cost of the test is 4400 AED, an investment in personal health that provides crucial information for individuals with a family history of melanoma or those at increased risk due to genetic factors. Early identification of susceptibility through this test can lead to proactive surveillance, early detection, and timely intervention, significantly improving outcomes for individuals at risk.
The "CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CDK4 gene that are linked to an increased risk of developing familial cutaneous malignant melanoma. The CDK4 gene plays a crucial role in the cell cycle, and mutations in this gene can lead to uncontrolled cell growth, a hallmark of cancer. This test is particularly relevant for individuals with a family history of melanoma, as it can provide vital information for early detection and prevention strategies. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the CDK4 gene. By opting for this test, individuals can take a proactive step towards managing their risk of developing melanoma, enabling them and their healthcare providers to implement personalized surveillance and prevention plans.
The PDGFB gene plays a crucial role in the development and growth of cells and tissues, including those in the brain. Mutations in the PDGFB gene have been associated with an increased risk of developing meningioma, a type of tumor that forms on membranes covering the brain and spinal cord. Familial PDGFB-related meningioma refers to cases where these genetic mutations are inherited, predisposing family members to the condition.
To identify individuals at risk, DNA Labs UAE offers a specialized genetic test focusing on the PDGFB gene. This test is designed to detect mutations in the PDGFB gene that could increase the likelihood of developing meningioma. By undergoing this test, individuals with a family history of meningiomas can better understand their risk and take proactive steps in monitoring and managing their health.
The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or cheek swab. The process is straightforward and conducted in a manner that ensures accuracy and confidentiality. Once the sample is analyzed, results are provided that detail any detected mutations in the PDGFB gene, allowing for a personalized approach to healthcare and preventive strategies.
DNA Labs UAE is known for its commitment to providing advanced genetic testing services, employing state-of-the-art technology and adhering to high standards of quality and reliability. This PDGFB gene test is an example of their dedication to offering valuable insights into inherited health risks, empowering individuals and families to make informed decisions about their health and well-being.
The SMARCE1 Gene Meningioma Familial Susceptibility Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SMARCE1 gene that are associated with an increased risk of developing meningioma, a type of brain tumor. Meningiomas are typically slow-growing tumors that form from the membranes covering the brain and spinal cord (meninges). Although many meningiomas are benign, they can be life-altering and, in rare cases, malignant.
The test is particularly relevant for individuals with a family history of meningioma or those who have a personal history of multiple meningiomas, as it can provide crucial information for risk assessment and management. Identifying a mutation in the SMARCE1 gene can help healthcare providers develop a personalized surveillance plan to detect and treat meningiomas early, potentially improving outcomes.
The cost of the SMARCE1 Gene Meningioma Familial Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, typically through a blood draw or a cheek swab, and comprehensive analysis in the lab. The test is conducted with strict confidentiality and precision, ensuring that patients receive accurate and useful information regarding their genetic risk for meningioma.
Given the implications of the test results for both the individual tested and potentially their family members, genetic counseling is often recommended as part of the testing process. This ensures that individuals fully understand the implications of the test results and can make informed decisions about their health and future surveillance options.
The "SUFU Gene Meningioma Familial Susceptibility to Genetic Test" is a highly specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SUFU gene, which are associated with an increased risk of developing meningioma and other related tumors. Meningiomas are tumors that arise from the meninges, the membranes that envelop the brain and spinal cord. Although many meningiomas are benign, they can lead to serious health issues depending on their size and location.
This genetic test is particularly valuable for individuals with a family history of meningiomas or those who have been diagnosed with conditions linked to SUFU gene mutations, as it can provide crucial information for early detection and prevention strategies. The test involves a simple blood or saliva sample from which DNA is extracted and analyzed for specific genetic alterations in the SUFU gene.
The cost of the "SUFU Gene Meningioma Familial Susceptibility to Genetic Test" at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this genetic test, the price reflects the intricate processes involved in ensuring accurate and reliable results, which can be pivotal in guiding patients' medical management and surveillance strategies for themselves and potentially at-risk family members.
The MN1 gene is associated with a type of brain tumor known as meningioma. Meningiomas are tumors that arise from the meninges, the membranous layers surrounding the brain and spinal cord. While many meningiomas are benign and grow slowly, some can be malignant and aggressive. The MN1 gene plays a role in cell cycle regulation and its mutations or alterations can contribute to the development and progression of meningiomas.
The MN1 Deficiency Related Genetic Test is a specialized diagnostic tool designed to detect mutations or deficiencies in the MN1 gene. This test is crucial for individuals who are at risk of developing meningiomas or for those who have been diagnosed with a meningioma, as it helps in understanding the genetic basis of the tumor. By identifying specific genetic alterations, healthcare providers can better predict the behavior of the tumor, including its potential growth rate and likelihood of recurrence after treatment. This information is invaluable for tailoring treatment plans to the individual's specific genetic profile, potentially improving outcomes.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the MN1 Deficiency Related Genetic Test is 4400 AED. DNA Labs UAE employs state-of-the-art technology and highly skilled professionals to ensure accurate and reliable test results. The facility provides a comprehensive service, including pre-test counseling to discuss the implications of the test results and post-test support to help patients and their families understand the next steps in management or treatment.
In summary, the MN1 Deficiency Related Genetic Test is a vital diagnostic tool for individuals with meningioma or at risk of developing this type of tumor. Available at DNA Labs UAE for 4400 AED, this test offers insights into the genetic factors contributing to meningioma development, aiding in personalized treatment planning and potentially improving patient outcomes.
The MLH1 Gene Mismatch Repair Cancer Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the MLH1 gene, which plays a crucial role in DNA mismatch repair. Mutations in this gene are associated with a significantly increased risk of developing various forms of cancer, most notably Lynch syndrome, which predisposes individuals to colorectal cancer, endometrial cancer, and several other types of cancer at a younger age than the general population. The test is particularly recommended for individuals with a family history of these cancers or those who have personal health histories that suggest the possibility of a genetic predisposition to cancer.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab. The sample is then analyzed to detect any mutations in the MLH1 gene that could impair the body's ability to repair DNA mismatches, a critical process in preventing cancer cell formation. The results of this test can provide invaluable information for both the individual tested and their family members, guiding healthcare decisions, including surveillance, preventative measures, or therapeutic interventions tailored to manage the increased cancer risk.
The cost of the MLH1 Gene Mismatch Repair Cancer Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment can be a critical step in proactive health management for those at risk, offering a chance to take preventive actions and make informed decisions about their health care and the health care of their relatives who might also be at risk.
The MSH2 Gene Mismatch Repair Cancer Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the MSH2 gene. These mutations are known to be associated with a significantly increased risk of developing various types of cancer, including colorectal, endometrial, and several other forms of cancer, as part of the Lynch syndrome or hereditary nonpolyposis colorectal cancer (HNPCC). The test, which costs 4400 AED, involves analyzing the patient's DNA to detect any abnormalities in the MSH2 gene that could impair the body's ability to repair DNA mismatches, a critical process in maintaining cellular health and preventing cancerous growths. By identifying these genetic mutations early, individuals can benefit from tailored surveillance strategies and preventive measures, potentially reducing the risk of cancer development and improving outcomes. DNA Labs UAE provides this test with the aim of supporting individuals and families in understanding their genetic health and taking proactive steps towards cancer prevention.
